Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Metals are commonly found in the environment, household, and workplaces in various forms, and a significant segment of the population is routinely exposed to the trace amount of metals from variety of sources. Exposure to metals, such as aluminum, lead, iron, and copper, from environment has long been debated as a potential environmental risk factor for Alzheimer's disease (AD) for decades, yet results from in vitro, in vivo, and human population remain controversial. In the case of copper, the neurotoxic mechanism of action was classically viewed as its strong affinity to amyloid-beta (Aβ) to help its aggregation and increase oxidative stress via Fenton reaction. Thus, it has been thought that accumulation of copper mediates neurotoxicity, and removing it from the brain prevents or reverse Aβ plaque burden. Recent evidence, however, suggests dyshomeostasis of copper and its valency in the body, instead of the accumulation and interaction with Aβ, are major determinants of its beneficial effects as an essential metal or its neurotoxic counterpart. This notion is also supported by the fact that genetic loss-of-function mutations on copper transporters lead to severe neurological symptoms. Along with its altered distribution, recent studies have also proposed novel mechanisms of copper neurotoxicity mediated by nonneuronal cell lineages in the brain, such as capillary endothelial cells, leading to development of AD neuropathology. This review covers recent findings of multifactorial toxic mechanisms of copper and discusses the risk of environmental exposure as a potential factor in accounting for the variability of AD incidence.

[1]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[2]  P. Pasqualetti,et al.  Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease , 2014, Annals of neurology.

[3]  K. Blennow,et al.  Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.

[4]  C. Troakes,et al.  Aluminium in brain tissue in familial Alzheimer's disease. , 2017, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[5]  Christine Van Broeckhoven,et al.  Genetic insights in Alzheimer's disease , 2013, The Lancet Neurology.

[6]  J. Prohaska,et al.  Role of copper transporters in copper homeostasis. , 2008, The American journal of clinical nutrition.

[7]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[8]  P. Hof,et al.  A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. , 1997, European neurology.

[9]  R. Dringen,et al.  Copper Oxide Nanoparticles Stimulate Glycolytic Flux and Increase the Cellular Contents of Glutathione and Metallothioneins in Cultured Astrocytes , 2014, Neurochemical Research.

[10]  H. Harris,et al.  Speciation of copper in a range of food types by X-ray absorption spectroscopy. , 2014, Food chemistry.

[11]  Ryuichi Morishita,et al.  Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors , 2013, Front. Aging Neurosci..

[12]  Jianxiu Wang,et al.  Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance† , 2007 .

[13]  Miles C. Miller,et al.  Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging , 2010, Journal of neuropathology and experimental neurology.

[14]  Mark A. Smith,et al.  Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion , 2011, Progress in Neurobiology.

[15]  Jianxiu Wang,et al.  Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance. , 2007, Biochemistry.

[16]  J. Schneider,et al.  Dietary copper and high saturated and trans fat intakes associated with cognitive decline. , 2006, Archives of neurology.

[17]  George J. Brewer,et al.  Copper-2 Ingestion, Plus Increased Meat Eating Leading to Increased Copper Absorption, Are Major Factors Behind the Current Epidemic of Alzheimer’s Disease , 2015, Nutrients.

[18]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[19]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[20]  E. Londos,et al.  Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease , 2008, Dementia and Geriatric Cognitive Disorders.

[21]  A. Loguinov,et al.  Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. , 2004, Physiological genomics.

[22]  L. Calderón-Garcidueñas,et al.  Air pollution: mechanisms of neuroinflammation and CNS disease , 2009, Trends in Neurosciences.

[23]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[24]  M. Ushio-Fukai,et al.  Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. , 2009, Free radical biology & medicine.

[25]  ATP7B Variants as Modulators of Copper Dyshomeostasis in Alzheimer’s Disease , 2013, NeuroMolecular Medicine.

[26]  Yang Yang,et al.  Copper Ion Binding Site in β-Amyloid Peptide. , 2016, Nano letters.

[27]  D. Sparks,et al.  Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Espinosa,et al.  A chemical speciation of trace metals for fine urban particles , 2002 .

[29]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[30]  R. Deane,et al.  Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance , 2013, Proceedings of the National Academy of Sciences.

[31]  P. Rossini,et al.  Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[32]  Xifei Yang,et al.  Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis. , 2015, Journal of Alzheimer's disease : JAD.

[33]  D. Holtzman,et al.  microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain , 2015, The Journal of Neuroscience.

[34]  D. Medeiros Gastric Bypass and Copper Deficiency: A Possible Overlooked Consequence , 2011, Obesity surgery.

[35]  I. Tooyama,et al.  Transition metal abnormalities in progressive dementias , 2011, BioMetals.

[36]  P. Pasqualetti,et al.  Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau , 2006, Neurology.

[37]  Urszula E. Wawrzyniak,et al.  A Functional Role for Aβ in Metal Homeostasis? N-Truncation and High-Affinity Copper Binding. , 2015, Angewandte Chemie.

[38]  R. Cappai,et al.  Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis. , 2014, Metallomics : integrated biometal science.

[39]  Ann Tiiman,et al.  Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity. , 2011, Metallomics : integrated biometal science.

[40]  K. Ragnarsdóttir,et al.  Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders , 2007, Neuropathology and applied neurobiology.

[41]  T. Beach,et al.  Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review , 2015, Current Alzheimer research.

[42]  A. Bush,et al.  Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease , 2010, Journal of neurochemistry.

[43]  G. Multhaup,et al.  Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-β Precursor Protein Gene* , 2004, Journal of Biological Chemistry.

[44]  T. Schneider-Axmann,et al.  ALZHEIMER’S DISEASE AND RELATED DISORDERS- ORIGINAL ARTICLE Intake , 2022 .

[45]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[46]  E. Andrási,et al.  Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. , 2005, Journal of Alzheimer's disease : JAD.

[47]  S. Kakimi,et al.  Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. , 2009, Journal of Inorganic Biochemistry.

[48]  D. Sparks,et al.  Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex. , 2015, Journal of Alzheimer's disease : JAD.

[49]  R. Katzman.,et al.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. , 2000, The Journal of clinical investigation.

[50]  G. Fang,et al.  Measurement and modeling of concentrations of ambient air particles, chromium, copper and lead pollutants concentrations, as well as dry deposition in central Taiwan , 2011, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[51]  Benjamin L. Oakes,et al.  Copper modulates the phenotypic response of activated BV2 microglia through the release of nitric oxide. , 2012, Nitric oxide : biology and chemistry.

[52]  V. Vasilevko,et al.  Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain. , 2014, Journal of Alzheimer's disease : JAD.

[53]  D. Sparks,et al.  Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. , 2006, The journal of nutrition, health & aging.

[54]  Colin L Masters,et al.  Gene knockout of amyloid precursor protein and amyloid precursor‐like protein‐2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts , 2004, Journal of neurochemistry.

[55]  G. Knapp,et al.  Occupational aluminum exposure: evidence in support of its neurobehavioral impact. , 2007, Neurotoxicology.

[56]  J. Quinn,et al.  Copper in Alzheimer’s disease: too much or too little? , 2009, Expert review of neurotherapeutics.

[57]  T. Bayer,et al.  Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  G. Barbati,et al.  Is cognitive function linked to serum free copper levels? A cohort study in a normal population , 2010, Clinical Neurophysiology.

[59]  R. Kukreti,et al.  Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population , 2017, Dementia and Geriatric Cognitive Disorders.

[60]  T. Lech,et al.  Copper Concentration in Body Tissues and Fluids in Normal Subjects of Southern Poland , 2007, Biological Trace Element Research.

[61]  R. Drucker-Colín,et al.  Nonoccupational environmental exposure to manganese is linked to deficits in peripheral and central olfactory function. , 2013, Chemical senses.

[62]  Shubhabrata Mukherjee,et al.  Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments , 2017, Alzheimer's & Dementia.

[63]  N. Delibaş,et al.  Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. , 2010, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[64]  P. Pasqualetti,et al.  Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals. , 2011, Journal of Alzheimer's disease : JAD.

[65]  Jianbin Wang,et al.  In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease* , 2017, The Journal of Biological Chemistry.

[66]  J. Provias,et al.  Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. , 2008, Current Alzheimer research.

[67]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[68]  R. Dringen,et al.  Copper-treatment increases the cellular GSH content and accelerates GSH export from cultured rat astrocytes , 2011, Neuroscience Letters.

[69]  J. Grutzendler,et al.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.

[70]  J. Finkelstein,et al.  Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System , 2006, Environmental health perspectives.

[71]  J. Koh,et al.  The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice , 2004, Neurobiology of Aging.

[72]  M. Kitazawa,et al.  Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  F. Tsai,et al.  Genetic variability in copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with Alzheimer's disease in a Chinese population. , 2013, Journal of biological regulators and homeostatic agents.

[74]  Yu Qiu,et al.  Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation , 2015, Journal of Neuroinflammation.

[75]  T. Bayer,et al.  Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier. , 2015, The Journal of clinical investigation.

[76]  S. Patassini,et al.  Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. , 2017, Metallomics : integrated biometal science.

[77]  T. Bayer,et al.  N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models , 2017, Alzheimer's Research & Therapy.

[78]  W. Bal,et al.  Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses , 2017, PloS one.

[79]  F. LaFerla,et al.  Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD , 2009, Journal of neurochemistry.